Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (7): 582-586    DOI: 10.19485/j.cnki.issn2096-5087.2023.07.007
  综述 本期目录 | 过刊浏览 | 高级检索 |
糖尿病与血管性痴呆发病的关联、病理机制及防治策略研究
张丹平 综述, 徐玲妙 审校
浙江省立同德医院痴呆康复中心,浙江 杭州 310012
Association, pathological mechanisms, prevention and control strategies of diabetes and vascular dementia: a review
ZHANG Danping, XU Lingmiao
Dementia Rehabilitation Center, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China
全文: PDF(796 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 血管性痴呆发病率逐年上升,目前缺乏有效治疗方法,因此降低血管性痴呆发病风险至关重要。研究表明糖尿病与血管性痴呆发病存在关联。本文收集1995年1月—2023年4月糖尿病与血管性痴呆相关的研究文献,对糖尿病与血管性痴呆发病的关联、病理机制和防治策略进行综述,发现糖尿病可通过诱导脑血管病、氧化应激和炎症反应加快血管性痴呆的发生发展,使用降糖药物、去除脑血管病诱因、维持血脑屏障稳定和坚持健康生活方式是现阶段血管性痴呆防治的主要措施。今后需进一步探索糖尿病诱发血管性痴呆的机制,寻求经济有效的防治靶点。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
张丹平
徐玲妙
关键词 糖尿病血管性痴呆病理机制防治策略    
Abstract:The incidence rate of vascular dementia is increasing year by year, and there is still no effective treatment at present, so it is very important to reduce the risk of developing vascular dementia. Research shows that diabetes is associated with vascular dementia. Based on the research literature related to diabetes and vascular dementia from January 1995 to April 2023, This article reviews the relationship between diabetes and vascular dementia, pathological mechanism and prevention and control strategies. It is found that diabetes can promote the occurrence and development of vascular dementia by inducing cerebrovascular disease, oxidative stress and inflammatory reaction, using hypoglycemic drugs, removing the incentives of cerebrovascular disease, maintaining the stability of blood-brain barrier and adhering to a healthy lifestyle are the main measures for the prevention and control of vascular dementia at this stage. Future research needs to further explore the mechanism of vascular dementia induced by diabetes, and seek economic and effective prevention targets.
Key wordsdiabetes mellitus    vascular dementia    pathological mechanism    prevention and control strategy
收稿日期: 2023-04-24      修回日期: 2023-06-28      出版日期: 2023-07-10
中图分类号:  R587.1  
作者简介: 张丹平,本科,护师,主要从事临床护理工作
通信作者: 徐玲妙,E-mail:382310493@qq.com   
引用本文:   
张丹平, 徐玲妙. 糖尿病与血管性痴呆发病的关联、病理机制及防治策略研究[J]. 预防医学, 2023, 35(7): 582-586.
ZHANG Danping, XU Lingmiao. Association, pathological mechanisms, prevention and control strategies of diabetes and vascular dementia: a review. Preventive Medicine, 2023, 35(7): 582-586.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.07.007      或      https://www.zjyfyxzz.com/CN/Y2023/V35/I7/582
[1] 曹晴. 痴呆患病率的研究[D].南京:南京医科大学,2020.
[2] 曲艳吉,卓琳,王华丽,等.1980—2011年中国社区55岁及以上人群中血管性痴呆流行病学的Meta分析[J].中国卒中杂志,2013,8(7):533-543.
[3] BIESSELS G J,DESPA F.Cognitive decline and dementia in diabetes mellitus:mechanisms and clinical implications[J].Nat Rev Endocrinol,2018,14(10):591-604.
[4] European Association for the Study of Diabetes(EASD)Annual Meeting.Study suggests heightened risk of dementia in individuals with type 2 diabetes varies by type of dementia[EB/OL].[2023-06-28].https://www.eurekalert.org/news-releases/599417.
[5] ZHENG B,SU B,PRICE G,et al.Glycemic control,diabetic complications,and risk of dementia in patients with diabetes:results from a large U.K. cohort study[J].Diabetes Care,2021,44(7):1556-1563.
[6] 王惠琴. 探讨糖尿病对血管性痴呆认知功能影响[J].现代实用医学,2013,25(12):1349-1350.
[7] 刘季红. 糖尿病对血管性痴呆认知功能的影响[J].糖尿病新世界,2015(2):95.
[8] 史云聪,郭艺芳.2型糖尿病和动脉粥样硬化性心血管病的关系[J].心血管病学进展,2020,41(5):485-490.
[9] MATSUMOTO L,SUZUKI K,MIZUNO Y,et al.Association of subclinical carotid atherosclerosis with immediate memory and other cognitive functions[J].Geriatr Gerontol Int,2018,18(1):65-71.
[10] DOUX J D,YUN A J.The link between carotid artery disease and ischemic stroke may be partially attributable to autonomic dysfunction and failure of cerebrovascular autoregulation triggered by Darwinian maladaptation of the carotid baroreceptors and chemoreceptors[J].Med Hypotheses,2006,66(1):176-181.
[11] 王志鹏,高仲磊,卫孟佳.脑小血管疾病磁共振成像表现与血管性认知功能障碍[J].中国临床医生杂志,2019,47(7):814-817.
[12] 刘杨颖秋. 2型糖尿病患者脑小血管疾病对认知相关结构和功能影响的多参数MRI研究[D].大连:大连医科大学,2022.
[13] DAULATZAI M A.Cerebral hypoperfusion and glucose hypometabolism:key pathophysiological modulators promote neurodegeneration,cognitive impairment,and Alzheimer's disease[J].J Neurosci Res,2017,95(4):943-972.
[14] QIN X,AKTER F,QIN L,et al.Adaptive immunity regulation and cerebral ischemia[J/OL].Front Immunol,2020,11[2023-06-28].https://doi.org/10.3389/fimmu.2020.00689.
[15] 李晶莹,赵伟东.糖尿病引发血脑屏障结构与功能失调机制的研究进展[J].中国老年学杂志,2022,42(9):2276-2282.
[16] CORNFORD E M,HYMAN S,CORNFORD M E,et al.Down-regulation of blood-brain glucose transport in the hyperglycemic nonobese diabetic mouse[J].Neurochem Res,1995,20(7):869-873.
[17] FERNANDS V,CHOUDHARY M,KUMAR A,et al.Proteotox-icity and mitochondrial dynamics in aging diabetic brain[J/OL].Pharmacol Res,2020,159[2023-06-28].https://doi.org/10.1016/j.phrs.2020.104948.
[18] GORSKA-CIEBIADA M,SARYUSZ-WOLSKA M,BORKOWSKA A,et al.Adiponectin,leptin and IL-1β in elderly diabetic patients with mild cognitive impairment[J].Metab Brain Dis,2016,31(2):257-266.
[19] ZHOU Y,ZHANG J,WANG L,et al.Interleukin-1β impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion[J].Brain Behav Immun,2017,60:93-105.
[20] 谢小莉,李燕,霍敏,等.老年2型糖尿病患者轻度认知功能障碍与胰岛素抵抗、白介素-6的相关性研究[J].医学信息,2019,32(15):97-98,108.
[21] YANG X,CHEN Y,ZHANG W,et al.Association between inflammatory biomarkers and cognitive dysfunction analyzed by mri in diabetes patients[J].Diabetes Metab Syndr Obes,2020,13:4059-4065.
[22] BELKHELFA M,BEDER N,MOUHOUB D,et al.The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia[J].J Neuroimmunol,2018,320:48-57.
[23] DYER A H,MCKENNA L,BATTEN I,et al.Peripheral inflammation and cognitive performance in middle-aged adults with and without type 2 diabetes:results from the ENBIND study[J/OL].Front Aging Neurosci,2020,12[2023-06-28].https://doi.org/10.3389/fnagi.2020.605878.
[24] BERTRAM S,BRIXIUS K,BRINKMANN C.Exercise for the diabetic brain:how physical training may help prevent dementia and Alzheimer's disease in T2DM patients[J].Endocrine,2016,53(2):350-363.
[25] SHEN D,TIAN X,SANG W,et al.Effect of melatonin and resveratrol against memory impairment and hippocampal damage in a rat model of vascular dementia[J].Neuroimmunomodulation,2016,23(5/6):318-331.
[26] HAMED S A.Brain injury with diabetes mellitus:evidence,mechanisms and treatment implications[J].Expert Rev Clin Pharmacol,2017,10(4):409-428.
[27] ESMAEILI M H,ENAYATI M,KHABBAZ-ABKENAR F,et al.Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease[J/OL].Behav Brain Res,2020,379[2023-06-28].https://doi.org/10.1016/j.bbr.2019.112359.
[28] GROENEVELD O N,KAPPELLE L J,BIESSELS G J.Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus[J].J Diabetes Investig,2016,7(1):5-16.
[29] HARDIGAN T,YASIR A,ABDELSAI M,et al.Linagliptin treatment improves cerebrovascular function and remodeling and restores reduced cerebral perfusion in type 2 diabetes[J].Am J Physiol Regul Integr Comp Physiol,2016,311(3):466-477.
[30] PINTANA H,APAIJAI N,CHATTIPAKORN N,et al.DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats[J].J Endocrinol,2013,218(1):1-11.
[31] GRIECO M,GIORGI A,GENTILE M C,et al.Glucagon-like peptide-1:a focus on neurodegenerative diseases[J/OL].Front Neurosci,2019,13[2023-06-28].https://doi.org/10.3389/fnins.2019.01112.
[32] PORTER K M,WARD M,HUGHES C F,et al.Hyperglycemia and metformin use are associated with B vitamin deficiency and cognitive dysfunction in older adults[J].J Clin Endocrinol Metab,2019,104(10):4837-4847.
[33] MILLER J W.Proton pump inhibitors,H2-receptor antagonists,metformin,and vitamin B-12 deficiency:clinical implications[J].Adv Nutr,2018,9(4):511-518.
[34] SONG J,WHITCOMB D J,KIM B C.The role of melatonin in the onset and progression of type 3 diabetes[J/OL].Mol Brain,2017,10(1)[2023-06-28].https://doi.org/10.1186/s13041-017-0315-x.
[35] BROOK E,MAMO J,WONG R,et al.Blood-brain barrier disturbances in diabetes-associated dementia:therapeutic potential for cannabinoids[J].Pharmacol Res,2019,141:291-297.
[36] SHANNON O M,RANSON J M,GREGORY S,et al.Mediterranean diet adherence is associated with lower dementia risk,independent of genetic predisposition:findings from the UK Biobank prospective cohort study[J].BMC Med,2023,21(1):1-13.
[37] ZUO X,ZHAO R,WU M,et al.Soy consumption and the risk of type 2 diabetes and cardiovascular diseases:a systematic review and meta-analysis[J/OL].Nutrients,2023,15[2023-06-28].https://doi.org/10.3390/nu15061358.
[38] OCHOA-ROSALES C,VAN-DER S N,BRAUN K V E,et al.C-reactive protein partially mediates the inverse association between coffee consumption and risk of type 2 diabetes:the UK Biobank and the Rotterdam study cohorts[J].Clin Nutr,2023,42(5):661-669.
[39] DEL-POZO C B,AHMADI M,NAISMITH S L,et al.Association of daily step count and intensity with incident dementia in 78 430 adults living in the UK[J].JAMA Neurol,2022,79(10):1059-1063.
[1] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[2] 陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
[3] 张凯慧, 李婉玲, 王彦兴, 安愿. 老年2型糖尿病患者心理灵活性、运动自我效能在衰弱与社会疏离间的中介效应分析[J]. 预防医学, 2025, 37(8): 783-788.
[4] 刘明坤, 张丰香, 韩彩静, 王霞, 陈世坤, 金梅, 孙金月. 2型糖尿病患者周围神经病变风险预测模型研究[J]. 预防医学, 2025, 37(7): 692-696.
[5] 俞丹丹, 杨加丽, 张雅萍, 许慧琳, 何丹丹, 李俊. 2型糖尿病共病患者空腹血糖波动轨迹的影响因素研究[J]. 预防医学, 2025, 37(6): 562-567,572.
[6] 李美琳, 周梦姣, 吴佳芸, 喻喆, 孔利萍. 老年男性2型糖尿病患者合并肌少症的影响因素分析[J]. 预防医学, 2025, 37(6): 588-592.
[7] 陆丽君, 袁磊, 李殿江, 卢昆, 朱怡萱, 王志勇, 刘思浚. 老年2型糖尿病患者自我效能、自我管理行为在抑郁症状与血糖控制间的中介效应分析[J]. 预防医学, 2025, 37(5): 455-459.
[8] 史美琦, 殷玉华, 汪旭虹, 付元庆, 苗泽蕾, 胡文胜. 妊娠糖尿病孕妇植物性饮食模式与孕期体重增加的关联研究[J]. 预防医学, 2025, 37(5): 503-506.
[9] 王英杰 综述, 孙高峰, 审校. 2型糖尿病预测模型研究进展[J]. 预防医学, 2025, 37(4): 369-372,377.
[10] 李倩, 杨柏林, 陈积标, 尹寒露, 许祝平, 孟晓军. 无锡市50岁及以上HIV/AIDS抗病毒治疗病例自报慢性病资料分析[J]. 预防医学, 2025, 37(4): 390-394.
[11] 孙霞, 但玲英, 郑鹏, 陈薪伊. 2型糖尿病患者脂肪因子与糖尿病视网膜病变的关联研究[J]. 预防医学, 2025, 37(3): 248-252.
[12] 陈海苗, 马岩, 刘明奇, 马珊珊, 李军, 方益荣. 儿童期肥胖与2型糖尿病、冠心病的孟德尔随机化研究[J]. 预防医学, 2025, 37(3): 307-311.
[13] 俞丹丹, 张雅萍, 许慧琳, 何丹丹, 梁彤彤, 杨加丽, 李俊. 糖尿病共病患者自我管理行为与时间洞察力的关联研究[J]. 预防医学, 2025, 37(2): 130-134.
[14] 文进博, 张婷, 赵倩, 刘景, 孙中明, 侯建斌, 陆正权, 许雨婷, 马新雄, 潘恩春. 2型糖尿病患者运动处方干预效果评价[J]. 预防医学, 2025, 37(12): 1211-1216.
[15] 刘雨欣, 梁丽军. 1990—2021年中国15~39岁人群糖尿病疾病负担趋势分析[J]. 预防医学, 2025, 37(12): 1242-1246.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed